RxNorm Semantic Concepts Index - 254
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "254".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 2540 | Cilastatin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2540 | Cilastatin | Designated preferred name (PT) | YES | |
| RxCUI: 2540 | Cilastatin | Full form of descriptor (FN) | YES | |
| RxCUI: 2540 | Cilastatin | Designated preferred name (PT) | YES | |
| RxCUI: 2540 | Cilastatin | Full form of descriptor (FN) | YES | |
| RxCUI: 2540130 | Schisandra chinensis fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2540131 | Tussilago farfara flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2540132 | Epimedium sagittatum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2540334 | Citrus aurantium flower wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2540430 | ALV-001 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2540431 | cenobamate 100 MG Oral Tablet (28) / cenobamate 150 MG Oral Tablet (28) Maintenance Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2540431 | cenobamate 100 MG Oral Tablet (28) / cenobamate 150 MG Oral Tablet (28) Maintenance Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2540431 | cenobamate 100 MG Oral Tablet (28) / cenobamate 150 MG Oral Tablet (28) Maintenance Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2540432 | XCOPRI 250 MG Maintenance Pack - 100 MG (28), 150 MG (28) 56 Count | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2540432 | XCOPRI 250 MG Maintenance Pack - 100 MG (28), 150 MG (28) 56 Count | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2540432 | XCOPRI 250 MG Maintenance Pack - 100 MG (28), 150 MG (28) 56 Count | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 25406 | nitrofurazone Topical Cream [Furacin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2540670 | Suavear | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2540671 | carbamide peroxide 65 MG/ML [Suavear] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2540672 | carbamide peroxide Otic Solution [Suavear] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2540673 | Suavear Otic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2540674 | SuavEar Earwax Removal Aid 6.5 % Otic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2540674 | SuavEar Earwax Removal Aid 6.5 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2540674 | SuavEar Earwax Removal Aid 6.5 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2540674 | SuavEar Earwax Removal Aid 6.5 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2540675 | glycerin 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2540675 | glycerin 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2540675 | glycerin 0.5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2540678 | PEG-12 glyceryl laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2540684 | meclizine Disintegrating Oral Tablet [Zentrip] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2540685 | Zentrip Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2540686 | Zentrip Disintegrating Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2540687 | ZenTrip 25 MG Disintegrating Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2540687 | ZenTrip 25 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2540687 | ZenTrip 25 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2540690 | risankizumab-rzaa 150 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2540691 | risankizumab Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2540692 | risankizumab-rzaa 150 MG in 1 mL Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2540692 | risankizumab-rzaa 150 MG in 1 mL Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2540692 | risankizumab-rzaa 150 MG in 1 mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2540692 | risankizumab-rzaa 150 MG in 1 mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2540693 | risankizumab-rzaa 150 MG/ML [Skyrizi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2540694 | risankizumab Auto-Injector [Skyrizi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2540695 | Skyrizi 150 MG in 1 mL Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2540695 | Skyrizi 150 MG in 1 mL Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2540695 | Skyrizi 150 MG in 1 mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2540695 | Skyrizi 150 MG in 1 mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2540696 | risankizumab-rzaa 150 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2540697 | risankizumab-rzaa 150 MG/ML Auto-Injector [Skyrizi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2540697 | risankizumab-rzaa 150 MG/ML Auto-Injector [Skyrizi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2540698 | risankizumab-rzaa 150 MG in 1 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2540698 | risankizumab-rzaa 150 MG in 1 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2540698 | risankizumab-rzaa 150 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2540698 | risankizumab-rzaa 150 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2540699 | Skyrizi 150 MG in 1 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2540699 | Skyrizi 150 MG in 1 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2540699 | Skyrizi 150 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2540699 | Skyrizi 150 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2540700 | risankizumab-rzaa 150 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2540701 | risankizumab-rzaa 150 MG/ML Prefilled Syringe [Skyrizi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2540701 | risankizumab-rzaa 150 MG/ML Prefilled Syringe [Skyrizi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2540702 | naloxone hydrochloride 80 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2540703 | naloxone hydrochloride 8 MG in 0.1 mL Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2540703 | naloxone hydrochloride 8 MG in 0.1 mL Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2540703 | naloxone hydrochloride 8 MG in 0.1 mL Nasal Spray | Designated preferred name (PT) | YES | |
| RxCUI: 2540703 | naloxone hydrochloride 8 MG in 0.1 mL Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2540703 | naloxone hydrochloride 8 MG in 0.1 mL Nasal Spray | Full form of descriptor (FN) | YES | |
| RxCUI: 2540704 | Kloxxado | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2540705 | naloxone hydrochloride 80 MG/ML [Kloxxado] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2540706 | naloxone Nasal Spray [Kloxxado] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2540707 | Kloxxado Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2540708 | Kloxxado Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2540709 | Kloxxado 8 MG in 0.1 mL Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2540709 | Kloxxado 8 MG in 0.1 mL Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2540709 | Kloxxado 8 MG in 0.1 mL Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2540709 | Kloxxado 8 MG in 0.1 mL Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2540919 | zinc oxide 0.049 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2540920 | zinc oxide 4.9 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2540920 | zinc oxide 4.9 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2540920 | zinc oxide 4.9 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2540920 | zinc oxide 4.9 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2540964 | loncastuximab tesirine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2540964 | loncastuximab tesirine | Designated preferred name (PT) | YES | |
| RxCUI: 2540964 | loncastuximab tesirine | Full form of descriptor (FN) | YES | |
| RxCUI: 2540964 | loncastuximab tesirine | Designated preferred name (PT) | YES | |
| RxCUI: 2540964 | loncastuximab tesirine | Full form of descriptor (FN) | YES | |
| RxCUI: 2540965 | loncastuximab tesirine-lpyl | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2540966 | loncastuximab tesirine-lpyl 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2540967 | loncastuximab tesirine Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2540967 | loncastuximab tesirine Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2540967 | loncastuximab tesirine Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2540968 | loncastuximab tesirine Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2540969 | loncastuximab tesirine-lpyl 10 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2540969 | loncastuximab tesirine-lpyl 10 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2540970 | Zynlonta | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2540971 | loncastuximab tesirine-lpyl 10 MG [Zynlonta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2540972 | loncastuximab tesirine Injection [Zynlonta] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2540973 | Zynlonta Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2540974 | Zynlonta 10 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2540974 | Zynlonta 10 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2540974 | Zynlonta 10 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2541 | Cimetidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2541 | Cimetidine | Designated preferred name (PT) | YES | |
| RxCUI: 2541 | Cimetidine | Full form of descriptor (FN) | YES | |
| RxCUI: 2541 | Cimetidine | Designated preferred name (PT) | YES | |
| RxCUI: 2541 | Cimetidine | Full form of descriptor (FN) | YES | |
| RxCUI: 2541052 | salicylic acid 0.15 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2541052 | salicylic acid 0.15 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2541052 | salicylic acid 0.15 % Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2541158 | chlorhexidine gluconate 3 % / climbazole 0.5 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2541158 | chlorhexidine gluconate 3 % / climbazole 0.5 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2541158 | chlorhexidine gluconate 3 % / climbazole 0.5 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2541159 | glycerin / phenylephrine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2541160 | chlorhexidine / climbazole | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2541161 | glycerin 0.25 % / phenylephrine hydrochloride 0.2 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2541161 | glycerin 0.25 % / phenylephrine hydrochloride 0.2 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2541161 | glycerin 0.25 % / phenylephrine hydrochloride 0.2 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2541162 | glycerin / phenylephrine Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2541163 | glycerin / phenylephrine Ophthalmic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2541164 | chlorhexidine / climbazole Topical Foam | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2541165 | chlorhexidine / climbazole Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2541166 | Citrus medica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2541170 | midazolam 50 MG in 50 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2541170 | midazolam 50 MG in 50 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2541170 | midazolam 50 MG in 50 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2541171 | midazolam 100 MG in 100 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2541171 | midazolam 100 MG in 100 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2541171 | midazolam 100 MG in 100 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2541230 | mirabegron 8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2541231 | mirabegron Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2541232 | mirabegron Extended Release Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2541233 | mirabegron 8 MG/mL 24HR Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2541233 | mirabegron 8 MG/mL 24HR Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2541233 | mirabegron 8 MG/mL 24HR Extended Release Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2541234 | mirabegron 8 MG/ML [Myrbetriq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2541235 | mirabegron Extended Release Suspension [Myrbetriq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2541236 | Myrbetriq Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2541237 | Myrbetriq Granules 8 MG/mL 24HR Extended Release Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2541237 | Myrbetriq Granules 8 MG/mL 24HR Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2541237 | Myrbetriq Granules 8 MG/mL 24HR Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2541237 | Myrbetriq Granules 8 MG/mL 24HR Extended Release Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2541238 | mirabegron 8 MG/ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2541239 | mirabegron 8 MG/ML Extended Release Suspension [Myrbetriq] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2541239 | mirabegron 8 MG/ML Extended Release Suspension [Myrbetriq] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2541497 | egg shell preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2541498 | Amaranthus hypochondriacus seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2541510 | valbenazine 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2541511 | valbenazine 60 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2541511 | valbenazine 60 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2541511 | valbenazine 60 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2541512 | valbenazine 60 MG [Ingrezza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2541513 | INGREZZA 60 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2541513 | INGREZZA 60 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2541513 | INGREZZA 60 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2541518 | deutetrabenazine starter pack 6 MG (28), 9 MG (28), 12 MG (14) Oral Tablet 4 Week Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2541518 | deutetrabenazine starter pack 6 MG (28), 9 MG (28), 12 MG (14) Oral Tablet 4 Week Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2541518 | deutetrabenazine starter pack 6 MG (28), 9 MG (28), 12 MG (14) Oral Tablet 4 Week Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2541519 | Austedo 12 MG Starting Dose, 4 Week Titration Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2541519 | Austedo 12 MG Starting Dose, 4 Week Titration Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2541519 | Austedo 12 MG Starting Dose, 4 Week Titration Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2541520 | deutetrabenazine starter pack 6 MG (21), 9 MG (14), 12 MG (14) Oral Tablet 4 Week Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2541520 | deutetrabenazine starter pack 6 MG (21), 9 MG (14), 12 MG (14) Oral Tablet 4 Week Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2541520 | deutetrabenazine starter pack 6 MG (21), 9 MG (14), 12 MG (14) Oral Tablet 4 Week Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2541932 | mannitol 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2541933 | Mannitol-containing product in pulmonary dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2541933 | Mannitol-containing product in pulmonary dose form | Designated preferred name (PT) | YES | |
| RxCUI: 2541933 | Mannitol-containing product in pulmonary dose form | Full form of descriptor (FN) | YES | |
| RxCUI: 2541934 | mannitol Inhalation Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2541936 | mannitol 40 MG [Bronchitol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2541937 | mannitol Inhalation Powder [Bronchitol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2541939 | Stephania sinica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 25421 | Furfurylmethylamphetamine | Designated preferred name (PT) | NO | |
| RxCUI: 25421 | Furfurylmethylamphetamine | Full form of descriptor (FN) | NO | |
| RxCUI: 25421 | Furfurylmethylamphetamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2542283 | Knoxia roxburghii subsp. brunonis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2542287 | Saccharomyces boulardii 400 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2542288 | Saccharomyces boulardii 400 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2542288 | Saccharomyces boulardii 400 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2542334 | benzalkonium chloride 0.2 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2542334 | benzalkonium chloride 0.2 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2542334 | benzalkonium chloride 0.2 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2542348 | guaiol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2542349 | .alpha.-terpinene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2542350 | .beta.-ocimene, (3Z)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2542732 | camphor 6 % / menthol 16 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2542732 | camphor 6 % / menthol 16 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2542732 | camphor 6 % / menthol 16 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2542744 | banana peel extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2542745 | Mentha pulegium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 25437 | Fusafungin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 25437 | Fusafungin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25437 | Fusafungin | Designated preferred name (PT) | NO | |
| RxCUI: 25437 | Fusafungin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25437 | Fusafungin | Full form of descriptor (FN) | NO | |
| RxCUI: 25437 | Fusafungin | Designated preferred name (PT) | NO | |
| RxCUI: 25437 | Fusafungin | Full form of descriptor (FN) | NO | |
| RxCUI: 2545 | Cinchona alkaloid | Designated preferred name (PT) | NO | |
| RxCUI: 2545 | Cinchona alkaloid | Full form of descriptor (FN) | NO | |
| RxCUI: 2545 | Cinchona alkaloid | Designated preferred name (PT) | NO | |
| RxCUI: 2545 | Cinchona alkaloid | Full form of descriptor (FN) | NO | |
| RxCUI: 25455 | Fybogel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2546 | Cinchophen | Designated preferred name (PT) | NO | |
| RxCUI: 2546 | Cinchophen | Full form of descriptor (FN) | NO | |
| RxCUI: 25480 | gabapentin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 25480 | gabapentin | Designated preferred name (PT) | YES | |
| RxCUI: 25480 | gabapentin | Full form of descriptor (FN) | YES | |
| RxCUI: 25480 | gabapentin | Designated preferred name (PT) | YES | |
| RxCUI: 25480 | gabapentin | Full form of descriptor (FN) | YES | |
| RxCUI: 2548035 | 1,3-butadiene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2548036 | butyl isovalerate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2548235 | sodium behenoyl lactylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2548236 | Lysine aspartate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2548236 | Lysine aspartate | Designated preferred name (PT) | NO | |
| RxCUI: 2548236 | Lysine aspartate | Full form of descriptor (FN) | NO | |
| RxCUI: 25483 | gadoteridol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 25483 | gadoteridol | Designated preferred name (PT) | YES | |
| RxCUI: 25483 | gadoteridol | Full form of descriptor (FN) | YES | |
| RxCUI: 25483 | gadoteridol | Designated preferred name (PT) | YES | |
| RxCUI: 25483 | gadoteridol | Full form of descriptor (FN) | YES | |
| RxCUI: 25485 | Gadopentetic acid | Designated preferred name (PT) | NO | |
| RxCUI: 25485 | Gadopentetic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 2548535 | Zzzquil Ultra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2548536 | doxylamine succinate 25 MG [Zzzquil Ultra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2548537 | doxylamine Oral Tablet [Zzzquil Ultra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2548538 | Zzzquil Ultra Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2548539 | Zzzquil Ultra Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2548540 | Zzzquil Ultra 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2548540 | Zzzquil Ultra 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2548540 | Zzzquil Ultra 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25486 | gadopentetate dimeglumine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2548675 | methylheptyl isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2548676 | 2,2',2'',2'''-((4-((2-hydroxyethyl)amino)-8-(piperidin-1-yl)pyrimido(5,4-D)pyrimidine-2,6-diyl)dinitrilo)tetraethanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2548730 | Lactobacillus acidophilus 100 Million UNT Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548730 | Lactobacillus acidophilus 100 Million UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548730 | Lactobacillus acidophilus 100 Million UNT Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2548731 | selinexor 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2548732 | selinexor 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548732 | selinexor 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2548733 | selinexor 60 MG Weekly Dose Carton Pack, 60 MG oral Tablet 4 Count Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2548733 | selinexor 60 MG Weekly Dose Carton Pack, 60 MG oral Tablet 4 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548733 | selinexor 60 MG Weekly Dose Carton Pack, 60 MG oral Tablet 4 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548734 | selinexor 60 MG [Xpovio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2548735 | XPOVIO 60 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2548735 | XPOVIO 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548735 | XPOVIO 60 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548736 | XPOVIO 60 MG Weekly Dose (60 MG Tablet) Carton Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2548736 | XPOVIO 60 MG Weekly Dose (60 MG Tablet) Carton Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548736 | XPOVIO 60 MG Weekly Dose (60 MG Tablet) Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548737 | selinexor 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2548738 | selinexor 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548738 | selinexor 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2548739 | selinexor 100 MG Weekly Dose Carton Pack, 50 MG oral Tablet 8 Count Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2548739 | selinexor 100 MG Weekly Dose Carton Pack, 50 MG oral Tablet 8 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548739 | selinexor 100 MG Weekly Dose Carton Pack, 50 MG oral Tablet 8 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548740 | selinexor 50 MG [Xpovio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2548741 | XPOVIO 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2548741 | XPOVIO 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548741 | XPOVIO 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548742 | XPOVIO 100 MG Weekly Dose (50 MG Tablet) Carton Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2548742 | XPOVIO 100 MG Weekly Dose (50 MG Tablet) Carton Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548742 | XPOVIO 100 MG Weekly Dose (50 MG Tablet) Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548761 | selinexor 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2548762 | selinexor 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548762 | selinexor 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2548763 | selinexor 80 MG Weekly Dose Carton Pack, 40 MG oral Tablet 8 Count Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2548763 | selinexor 80 MG Weekly Dose Carton Pack, 40 MG oral Tablet 8 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548763 | selinexor 80 MG Weekly Dose Carton Pack, 40 MG oral Tablet 8 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548763 | selinexor 80 MG Weekly Dose Carton Pack, 40 MG oral Tablet 8 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548764 | selinexor 40 MG [Xpovio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2548765 | XPOVIO 40 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2548765 | XPOVIO 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548765 | XPOVIO 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548766 | XPOVIO 80 MG Weekly Dose (40 MG Tablets) Carton Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2548766 | XPOVIO 80 MG Weekly Dose (40 MG Tablets) Carton Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548766 | XPOVIO 80 MG Weekly Dose (40 MG Tablets) Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548767 | XPOVIO 40 MG Twice Weekly Dose (40 MG Tablets) Carton Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2548767 | XPOVIO 40 MG Twice Weekly Dose (40 MG Tablets) Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548767 | XPOVIO 40 MG Twice Weekly Dose (40 MG Tablets) Carton Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548768 | selinexor 40 MG Weekly Dose Carton Pack, 40 MG oral Tablet 4 Count Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2548768 | selinexor 40 MG Weekly Dose Carton Pack, 40 MG oral Tablet 4 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548768 | selinexor 40 MG Weekly Dose Carton Pack, 40 MG oral Tablet 4 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548769 | XPOVIO 40 MG Weekly Dose (40 MG Tablet) Carton Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2548769 | XPOVIO 40 MG Weekly Dose (40 MG Tablet) Carton Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548769 | XPOVIO 40 MG Weekly Dose (40 MG Tablet) Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548832 | Regoxidine 5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2548832 | Regoxidine 5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2548832 | Regoxidine 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2548833 | salicylic acid 5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548833 | salicylic acid 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548833 | salicylic acid 5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2548882 | menthol 5.4 MG [Therastat] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2548883 | THERASTAT 5.4 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2548883 | THERASTAT 5.4 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548883 | THERASTAT 5.4 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548888 | menthol 5.8 MG [Therastat] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2548889 | Therastat 5.8 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2548889 | Therastat 5.8 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548889 | Therastat 5.8 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548890 | menthol 7.5 MG [Thoracol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2548891 | THORACOL 7.5 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2548891 | THORACOL 7.5 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2548891 | THORACOL 7.5 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2548892 | nicotine 2 MG [Habitrol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2548893 | nicotine Oral Lozenge [Habitrol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2548894 | Habitrol Lozenge Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2548895 | Habitrol Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2548896 | Habitrol 2 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2548896 | Habitrol 2 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2548896 | Habitrol 2 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2548897 | nicotine 4 MG [Habitrol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2548898 | Habitrol 4 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2548898 | Habitrol 4 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2548898 | Habitrol 4 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2548899 | Baptisia tinctoria whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2548930 | tridecyl ethyleneglycol monoether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2549 | Cinnarizine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2549 | Cinnarizine | Designated preferred name (PT) | NO | |
| RxCUI: 2549 | Cinnarizine | Full form of descriptor (FN) | NO | |
| RxCUI: 2549 | Cinnarizine | Designated preferred name (PT) | NO | |
| RxCUI: 2549 | Cinnarizine | Full form of descriptor (FN) | NO | |
| RxCUI: 2549030 | pseudoephedrine sulfate 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2549031 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / pseudoephedrine sulfate 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2549031 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / pseudoephedrine sulfate 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2549031 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / pseudoephedrine sulfate 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2549032 | acetaminophen / dextromethorphan / triprolidine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2549033 | acetaminophen / dextromethorphan / triprolidine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2549034 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / triprolidine hydrochloride 1.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2549034 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / triprolidine hydrochloride 1.25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2549034 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / triprolidine hydrochloride 1.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2549035 | acetaminophen / dextromethorphan / phenylephrine / triprolidine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2549036 | acetaminophen / dextromethorphan / phenylephrine / triprolidine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2549037 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG / triprolidine hydrochloride 1.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2549037 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG / triprolidine hydrochloride 1.25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2549037 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG / triprolidine hydrochloride 1.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2549197 | steareth-2 phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2549198 | amivantamab-vmjw | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2549199 | amivantamab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2549199 | amivantamab | Designated preferred name (PT) | YES | |
| RxCUI: 2549199 | amivantamab | Full form of descriptor (FN) | YES | |
| RxCUI: 2549199 | amivantamab | Designated preferred name (PT) | YES | |
| RxCUI: 2549199 | amivantamab | Full form of descriptor (FN) | YES | |
| RxCUI: 2549330 | pegfilgrastim Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2549331 | pegfilgrastim 6 MG in 0.6 mL On-body Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2549331 | pegfilgrastim 6 MG in 0.6 mL On-body Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2549331 | pegfilgrastim 6 MG in 0.6 mL On-body Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2549331 | pegfilgrastim 6 MG in 0.6 mL On-body Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2549332 | pegfilgrastim Injection [Neulasta] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2549333 | Neulasta Onpro 6 MG in 0.6 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2549333 | Neulasta Onpro 6 MG in 0.6 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2549333 | Neulasta Onpro 6 MG in 0.6 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2549334 | pegfilgrastim 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2549335 | pegfilgrastim 10 MG/ML Injection [Neulasta] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2549335 | pegfilgrastim 10 MG/ML Injection [Neulasta] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 25497 | Galactan polysulfate | Designated preferred name (PT) | NO | |
| RxCUI: 25497 | Galactan polysulfate | Full form of descriptor (FN) | NO | |
| RxCUI: 2549731 | amivantamab-vmjw 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2549732 | amivantamab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2549732 | amivantamab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2549732 | amivantamab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2549733 | amivantamab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2549734 | amivantamab-vmjw 350 MG in 7 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2549734 | amivantamab-vmjw 350 MG in 7 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2549734 | amivantamab-vmjw 350 MG in 7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2549734 | amivantamab-vmjw 350 MG in 7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2549735 | Rybrevant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2549736 | amivantamab-vmjw 50 MG/ML [Rybrevant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2549737 | amivantamab Injection [Rybrevant] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2549738 | Rybrevant Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2549739 | Rybrevant 350 MG in 7 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2549739 | Rybrevant 350 MG in 7 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2549739 | Rybrevant 350 MG in 7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2549739 | Rybrevant 350 MG in 7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2549740 | amivantamab-vmjw 50 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2549741 | amivantamab-vmjw 50 MG/ML Injection [Rybrevant] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2549741 | amivantamab-vmjw 50 MG/ML Injection [Rybrevant] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2549742 | chlorhexidine / miconazole Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2549743 | chlorhexidine / miconazole Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2549744 | chlorhexidine gluconate 2 % / miconazole nitrate 2 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2549744 | chlorhexidine gluconate 2 % / miconazole nitrate 2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2549744 | chlorhexidine gluconate 2 % / miconazole nitrate 2 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2549745 | chlorhexidine / miconazole Topical Foam | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2549746 | chlorhexidine gluconate 2 % / miconazole nitrate 2 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2549746 | chlorhexidine gluconate 2 % / miconazole nitrate 2 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2549746 | chlorhexidine gluconate 2 % / miconazole nitrate 2 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2549747 | epigallocatechin gallatyl glucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2549831 | tepraloxydim | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |